Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 February, 2019 19:08 IST
Alembic Pharma receives nod for Doxycycline Hyclate capsules
Source: IRIS | 14 Jun, 2018, 11.09AM
Comments  |  Post Comment

Alembic Pharmaceuticals today announced that the company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Hyclate Capsules USP, 50 mg and 100 mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vibramycin Capsules, 50 mg and 100 mg, of Pfizer Inc. Doxycycline is indicated for a wide variety of bacterial infections including those caused by several gram-negative as well as gram-positive microorganisms. Doxycycline is also indlcated for the prophylaxis of malaria due to Plasmodium falciparum in short-term travelers (<4 months) to areas with chloroquine and/or pyrimethaminesulfadoxine resistant strains. Doxycycline may be a useful adjunctive therapy in severe acne and in acute intestinal amebiasis.

Doxycycline Hyclate Capsules USP, 50 mg and 100 mg, have an estimated market size of USD 80 million for twelve months ending December 2017 according to IQVIA.

Alembic now has a total of 73 ANDA approvals (65 final approvals and 8 tentative approvals) from USFDA.

Shares of the company gained Rs 16.2, or 3.16%, to trade at Rs 529.00. The total volume of shares traded was 27,704 at the BSE (10.59 a.m., Thursday).





Alembic Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Cipla, Wellthy Therapeutics announce partnership to offer digital therapeutics - 19-Feb-2019 10:58
Glenmark Pharma receives ANDA approval for Clobetasol propionate foam - 18-Feb-2019 10:45
L&T Construction secures contract for design and construction of major airport - 18-Feb-2019 10:42
Lupin launches Clobazam oral suspension - 15-Feb-2019 16:37
Zydus gets USFDA nod for Triamterene & Hydrochlorothiazide capsules - 13-Feb-2019 13:10
L&T Construction bags contract for construction of hospitals - 13-Feb-2019 11:56
Strides receives USFDA approval for Triamcinolone Acetonide cream - 13-Feb-2019 11:52
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer